Reluctant English physicians cite concern about unknown long-term effects. Read More
The industry veteran will lead the firm's European sales and international expansion. Read More
The most recent version of the Build Back Better Act makes no mention of the proposed hike. Read More
Moving to synthetic nicotine was ‘a forced innovation,’ the firm's leaders tell The Wall Street Journal. Read More
TMA 2021 will feature regulatory leaders, industry representatives and others.Read More
Updated guidance would permit doctors to prescribe licensed vapor products for cessation. Read More
The product features a striking design and multiple advanced technologies.Read More
The company is still seeking a judicial stay pending the outcome of its lawsuit. Read More
Judges say the FDA pulled a “surprise switcheroo” in changing its PMTA guidance.Read More
It remains unclear whether the FDA will continue to withdraw more marketing denials, courts issuing stays.Read More
